Artificial intelligence is becoming an increasingly important tool in clinical diagnostics, helping healthcare professionals process complex medical data more efficiently while supporting faster decision-making. Natus Medical Incorporated has expanded the availability of its autoSCORE™ AI analysis tool by integrating it into BRAIN QUICK® Software, extending access to AI-assisted electroencephalography (EEG) interpretation across Europe and other international markets following the technology’s recent CE marking.
Natus Medical Incorporated has broadened the international rollout of its AI-powered EEG analysis technology by integrating the autoSCORE™ analysis tool into the latest version of BRAIN QUICK® Software. The expansion follows the solution’s CE marking earlier this year and represents the company’s latest effort to incorporate artificial intelligence into clinical neurodiagnostic workflows beyond the United States.
The integration builds on autoSCORE’s initial launch with Natus NeuroWorks® EEG Software in the U.S. in 2024. By making the technology available across two of its flagship EEG platforms, Natus is extending AI-assisted neurological analysis to a wider network of hospitals, epilepsy centers and neurophysiology laboratories.
The announcement reflects a broader trend in healthcare, where AI is increasingly being deployed to augment clinical decision-making rather than replace physician expertise. Healthcare technology companies, including Microsoft, Google, NVIDIA, GE HealthCare, Philips, and Siemens Healthineers, continue to invest in AI-driven diagnostic imaging, predictive analytics and clinical workflow automation as healthcare systems seek to improve efficiency amid rising demand for specialist care.
Electroencephalography remains one of the most important diagnostic tools for evaluating neurological disorders such as epilepsy, seizure disorders, encephalopathy and other abnormalities affecting brain activity. However, interpreting EEG recordings can be time-intensive, requiring highly trained neurologists to review lengthy recordings containing thousands of waveform patterns.
Natus says the autoSCORE algorithm is designed to reduce that workload by applying deep learning to automate portions of EEG interpretation. According to the company, the model was trained using approximately 30,000 expertly labeled EEG recordings, enabling it to identify clinically significant abnormalities while providing study-level assessments that classify examinations as normal or abnormal.
Unlike conventional AI systems that focus primarily on detecting seizures or epileptic spikes, autoSCORE evaluates multiple clinically relevant EEG abnormalities across an entire recording. The system is intended to support neurologists by highlighting findings that require clinical attention while maintaining physician oversight for diagnosis and treatment decisions.
The technology also employs what Natus describes as a closed AI model, an approach designed to prioritize consistency, security and reproducibility within regulated clinical environments. Closed models are increasingly favored in healthcare settings because they allow institutions to validate AI behavior under controlled conditions while supporting regulatory compliance and patient safety.
The integration into BRAIN QUICK Software expands AI functionality beyond automation by embedding intelligent analysis directly into clinical review and reporting workflows. Clinicians can use AI-generated assessments alongside conventional EEG review, potentially reducing manual interpretation time and accelerating reporting for high-volume neurodiagnostic departments.
Healthcare providers participating in early deployments have reported positive operational outcomes. According to Natus, clinicians using the latest version of BRAIN QUICK highlighted the software’s recording reliability in complex environments, including presurgical epilepsy evaluations where high-quality EEG interpretation plays a critical role in treatment planning.
From an enterprise healthcare perspective, AI-assisted neurodiagnostics address several growing challenges facing neurological care. Many healthcare systems continue to experience shortages of neurologists and clinical neurophysiologists while demand for EEG testing continues to increase due to aging populations and rising awareness of neurological disorders.
AI-supported interpretation tools can help standardize preliminary analysis, reduce clinician workload and improve workflow efficiency without replacing specialist expertise. Instead, these systems function as clinical decision support technologies that enable physicians to spend more time evaluating complex cases and making final diagnostic decisions.
Industry analysts expect AI to play an expanding role across diagnostic medicine. According to McKinsey & Company, generative AI and machine learning are poised to improve productivity throughout healthcare by streamlining administrative processes and enhancing clinical decision support. Meanwhile, Gartner has identified AI-assisted diagnostics as one of the fastest-growing enterprise applications within healthcare technology, driven by advances in deep learning, medical imaging and predictive analytics.
The integration also reflects a larger evolution in neurodiagnostics. Digital EEG systems transformed neurological testing several decades ago by replacing analog recording methods with computerized analysis. AI represents the next stage of that progression by introducing intelligent pattern recognition capable of supporting clinicians as EEG datasets become larger and more complex.
With autoSCORE now available across both NeuroWorks and BRAIN QUICK platforms, Natus has established a broader AI-enabled neurodiagnostic ecosystem serving healthcare providers in North America, Europe and other international markets.
As hospitals continue investing in digital health technologies, AI-assisted EEG interpretation is likely to become an increasingly valuable component of neurological care. Rather than replacing clinician expertise, platforms such as autoSCORE demonstrate how artificial intelligence can augment diagnostic workflows, improve efficiency and support faster access to neurological assessment while maintaining physician oversight.
Market Landscape
Artificial intelligence is rapidly transforming diagnostic medicine by supporting clinicians with automated image analysis, predictive modeling and clinical decision support.
Technology companies including Microsoft, Google, NVIDIA, GE HealthCare, Philips, and Siemens Healthineers continue expanding AI capabilities across radiology, pathology, cardiology and neurology. According to McKinsey & Company, AI has the potential to significantly improve healthcare productivity through workflow automation and enhanced clinical decision-making, while Gartner expects AI-assisted diagnostics to become a core component of digital healthcare infrastructure over the next decade.
Top Insights
- Natus expanded its autoSCORE AI tool to BRAIN QUICK Software, extending AI-assisted EEG interpretation across Europe and international healthcare markets following CE certification.
- The deep learning model was trained on approximately 30,000 expertly labeled EEG recordings, enabling automated identification of multiple clinically significant neurological abnormalities.
- Unlike traditional seizure detection tools, autoSCORE provides study-level EEG assessments, helping neurologists classify recordings as normal or abnormal while supporting clinical review.
- The platform employs a closed AI model, emphasizing consistency, security and reproducibility for regulated healthcare environments and enterprise clinical workflows.
- AI-assisted EEG analysis aims to improve diagnostic efficiency, allowing neurologists to spend less time on manual waveform review and more time on patient-centered decision-making.
Power Tomorrow’s Intelligence — Build It with TechEdgeAI
